Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06913764Not ApplicableCompleted

First- or Second- Class Compression Hosiery After Endovenous Laser With Sclerotherapy and Ambulatory Phlebectomy

Role: collaborator

NCT06288633Not ApplicableRecruiting

Cardioneuroablation for Bradyarrhythmia

Role: collaborator

NCT05311787Not ApplicableRecruiting

The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery

Role: lead

NCT04741152Completed

Blinded Resection in Case of the Pancreatic Insulinoma

Role: lead

All 4 trials loaded